[1]
|
W. Lenz, “Thalidomide and Congenital Abnormalities,” The Lancet, 1962, I. 45.
|
[2]
|
W. Lenz, “A Short History of Thalido-mide Embryopathy,” Teratology, Vol. 38, No. 3, 1988, pp. 203-215.
doi:10.1002/tera.1420380303
|
[3]
|
B. J. Yuan and Z. Q. Wang, “The Purpose and the Sig- nificance of Preclinical Safety Evaluation,” Military Medical Science Press, Beijing, 1997.
|
[4]
|
L. Y. Xia, “Modern Toxicology of Chinese Medi-cine,” Tianjin Science and Technology Translation and Pub-lishing Corporation, Tianjin, 2005.
|
[5]
|
J. L. Li, “Animal Ex-perimental Studies of ‘Eighteen Clashes’ of Chinese Medicinal Herbs,” Journal of Chang- chun College of Traditional Chinese Medicine, Vol. 2, No. 3, 1988, p. 89.
|
[6]
|
X. S. Gao, “Eighteen Clashes Research of Chinese Medicinal Herbs,” Chinese An-cient Books Publishing House, Beijing, 1991.
|
[7]
|
J. Lu, “Studies on the Aristolochic Acid Related Crude Traditional Chinese Medicine,” Drug Standards of China, Vol. 3, No. 2, 2002, pp. 49-50.
|
[8]
|
L. S. Wang, “Toxic Effects of Aris-tolochic Acid,” Traditional Chinese Drug Research & Clinical Pharmacology, Vol. 12, No. 6, 2001, pp. 394-395.
|
[9]
|
G. Z. Jiang and L. Chen, “New Research Progress of Toxicity of Aristolochic Acid in Traditional Chinese Medicine,” Chinese Agricultural Science Bulletin, Vol. 24, No. 9, 2008, pp. 84-87.
|
[10]
|
N. K. Ho, “Traditional Chinese Medicine and Treatment of Neonatal Jaundice,” Singapore Medical Journal, Vol. 37, No. 6, 1996, pp. 645-651.
|
[11]
|
L. Zhang, S. H. Gao, C. F. Zhou, et al., “Safety Issues of Traditional Chinese Medical Preparations Containing Ar- senic Substances: Review Starting from Niuhuang Jiedu Pian (Wan),” China Journal of Chinese Materia Medica, Vol. 31, No. 23, 2006, pp. 2010-2012.
|
[12]
|
P. Li, “Research Status of Traditional Medicine Cinnabar,” West China Journal of Pharmaceutical Sciences, Vol. 25, No. 5, 2010, pp. 622-624.
|
[13]
|
K. Yang, X. F. Li, Q. H. Li and G. H. Ding, “Overview of Adverse Reactions of Chinese Medicine Containing Heavy Metals and Arsenic,” Chinese Journal of Hospital Pharmacy, Vol. 28, No. 4, 2008, pp. 301-304.
|
[14]
|
D. X. Wang and X. L. Zhu, “Poisoning of Traditional Chinese Mineral Medicines Containing Heavy Metal: Clinical Presenta-tion and Management,” Adverse Drug Reactions Journal, Vol. 9, No. 1, 2007, pp. 43-45.
|
[15]
|
R. L. Page and J. D. Lawrence, “Potentiation of Warfarin by Dong Quai,” Pharmacotherapy, Vol. 19, No. 7, 1999, pp. 870-876. doi:10.1592/phco.19.10.870.31558
|
[16]
|
B. Cheng, C. T. Hung and W. Chiu, “Herbal Medicine and Anaesthesia,” Hong Kong Medical Journal, Vol. 8, No. 2, 2002, pp. 123-130.
|
[17]
|
A. A. Izzo and E. Ernst, “Interactions between Herbal Medicines and Prescribed Drugs: A Systematic Review,” Drugs, Vol. 61, No. 15, 2001, pp. 2163-2175.
doi:10.2165/00003495-200161150-00002
|
[18]
|
A. Fugh-Berman, “Herb-Drug Interactions,” The Lancet, Vol. 355, No. 9198, 2000, pp. 134-138.
doi:10.1016/S0140-6736(99)06457-0
|
[19]
|
Z. H. Zhang, “Ru Men Shi Qing,” The Yuan Dynasty, AD1300.
|
[20]
|
The American Society of Anesthesiologists, “Anesthesiologists Warn: If You’re Taking Herbal Products, Tell Your Doctor before Surgery,” 2001.
|
[21]
|
J. Doucet, P. Chassagne, C. Trivalle, I. Landrin, M. D. Panty, N. Kadri, J. F. Menard and E. Bercoff, “Drug-Drug Interactions Related to Hospital Admini-strations in Older Adults: A Prospective Study of 1000 Pa-tients,” Journal of American Geriatric Society, Vol. 44, No. 8, 1996, pp. 944-948.
|
[22]
|
X. A. Zhang, “Drug Induced Dis-eases,” China Medical Technology Publishing House, Beijing, 1997.
|
[23]
|
D. M. Tan, “Abuse of Aloe Vera,” Science Daily, Vol. 30, 2001.
|
[24]
|
J. M. Zhang, “Excessive Intake of Licorice can Cause Potassium Loss,” International Journal of Tradi-tional Chinese Medicine, Vol. 14, No. 6, 1992, p. 14.
|
[25]
|
J. Hu, Ji. Fang, Y. Dong, S. J. Chen and Z. Chen, “Arsenic in Cancer Therapy,” Anticancer Drugs, Vol. 16, No. 2, 2005, pp. 119-127.
doi:10.1097/00001813-200502000-00002
|
[26]
|
Q. L. Li, “One Case of Allergic Purpura Caused by Excessive Aristolochia Manshuriensis Decoction,” China Journal of Chinese Materia Medica, Vol. 25, No. 2, 2000, p. 124.
|
[27]
|
K. B. Bi and Y. L. Jia, “1 Case of Acute Renal Failure Induced by Overdose of Tripterygium Decoction,” China Journal of Chinese Materia Medica, Vol. 25, No. 3, 2000, p. 191.
|
[28]
|
Z. Y. Cau, “Clinical Analysis of 72 Cases of Acute Poisoning after Oral Triptery-gium,” Hunan Journal of Traditional Chinese Medicine, Vol. 8, No. 2, 1981, p. 17-19.
|
[29]
|
J. Z. Wang, “3 Cases of Tonkinen-sis Poisoning Report,” Clinical Medicine, Vol. 8, No. 6, 1988, p. 279.
|
[30]
|
Y. M. Wen, “One Death Case of Poisoning after Oral Taking Radix Sophorae Tonkinensis,” Chinese Journal of Hos-pital Pharmacy, Vol. 11, No. 6, 1991, p. 271.
|
[31]
|
G. T. Zhang and A. Y. Zhao, “Improper Combination of Proprietary Chinese Medicine in Clinical Practice,” Chinese Journal of Hospital Pharmacy, Vol. 191, No. 10, 1999, p. 621.
|
[32]
|
“52 Kinds of Hospital Inhibited Plants Which Contain ‘Epsteln-Barr Virus Early Antigen-Inducer’ Have Cancer- promoting Effects,” Chinese Hospital Architecture & Equipment, Vol. 4, 2003, p. 11.
|
[33]
|
W. L. Xue, “From the Safety of Traditional Chinese Medicine to Its Internationalization,” Information on Tradi-tional Chinese Medicine, Vol. 22, No. 2, 2005, pp. 6-7.
|
[34]
|
Y. P. Xiao, X. H. Ren and Y. X. Wu, “Lianyuan City Drug Ad-verse Reaction Analysis Report,” Journal of Clinical and Ex-perimental Medicine, Vol. 6, No. 5, 2007, pp. 172-173.
|
[35]
|
S. T. Yuan, “Consideration on the Problem of Ascension of the Case Poisoned by Chinese Traditional Medicines,” China Journal of Chinese Materia Medica, Vol. 25, No. 1, 2000, p. 56.
|
[36]
|
Chinese Medicine Council of Hong Kong, “Registra-tion of Proprietary Chinese Medicine (Application Handbook),” 2004.
|
[37]
|
J. Ma, “The Relationship between Drug Toxicology and Other Disciplines,” Shanghai National Center for New Drug Safety Evaluation GLP Training Seminars, Cheng-du, 6 March 2011.
|
[38]
|
H. Olson, G. Betton, D. Robjnson, et al., “Concordance of the Toxicity of Pharmaceuticals in Humans and Animals,” Regulatory Toxicology and Pharmacology, Vol. 32, No. 1, 2000, pp. 56-67. doi:10.1006/rtph.2000.1399
|
[39]
|
L. X. Yang, “Toxicology Studies of Artemisinin and Its Deriva-tives,” Journal of Traditional Chinese Medicine, Vol. 1, No. 1, 1982, pp. 3-6.
|
[40]
|
Center for Evaluation and Research, “Annual Report of 2001 to Nation,” 2001.
http://www.fda.gov/eder/reports/rtn/2001
|